These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37818362)

  • 1. Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases.
    Tseng H; Stone C; Murrell DF
    Front Immunol; 2023; 14():1243581. PubMed ID: 37818362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing Minimal Clinically Important Differences (MCIDs) for the Pemphigus Disease Area Index (PDAI).
    Tseng H; Stone C; Shulruf B; Murrell DF
    Br J Dermatol; 2024 Jul; ():. PubMed ID: 39001612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunopathological characteristics of autoimmune blistering skin diseases.
    Gunarić A; Šimić D; Marinović B
    Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):141-149. PubMed ID: 38126096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art review of human autoimmune blistering diseases (AIBD).
    Zeng FAP; Murrell DF
    Vet Dermatol; 2021 Dec; 32(6):524-e145. PubMed ID: 34351020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Clinical Trials in Pemphigus and Pemphigoid.
    Izumi K; Bieber K; Ludwig RJ
    Front Immunol; 2019; 10():978. PubMed ID: 31130959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological therapy of autoimmune blistering diseases.
    Alaibac M
    Expert Opin Biol Ther; 2019 Feb; 19(2):149-156. PubMed ID: 30558452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
    Raap U; Limberg MM; Kridin K; Ludwig RJ
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
    Ogura K; Yakoub MA; Christ AB; Fujiwara T; Nikolic Z; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2020 Sep; 478(9):2148-2158. PubMed ID: 32568896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a distribution-based approach and systematic review methods to derive minimum clinically important differences.
    Watt JA; Veroniki AA; Tricco AC; Straus SE
    BMC Med Res Methodol; 2021 Feb; 21(1):41. PubMed ID: 33637039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation studies of outcome measures in pemphigus.
    Hanna S; Kim M; Murrell DF
    Int J Womens Dermatol; 2016 Dec; 2(4):128-139. PubMed ID: 28492025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial Inconsistency and Variability Exists Among Minimum Clinically Important Differences for Shoulder Arthroplasty Outcomes: A Systematic Review.
    Kolin DA; Moverman MA; Pagani NR; Puzzitiello RN; Dubin J; Menendez ME; Jawa A; Kirsch JM
    Clin Orthop Relat Res; 2022 Jul; 480(7):1371-1383. PubMed ID: 35302970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
    Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
    J Am Acad Dermatol; 2021 Jun; 84(6):1523-1537. PubMed ID: 33684497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune bullous diseases in pregnancy: an overview of pathogenesis, clinical presentations, diagnostics and available therapies.
    Vičić M; Marinović B
    Ital J Dermatol Venerol; 2023 Apr; 158(2):99-109. PubMed ID: 37153944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune blistering diseases: promising agents in clinical trials.
    Olbrich H; Sadik CD; Schmidt E
    Expert Opin Investig Drugs; 2023; 32(7):615-623. PubMed ID: 37526503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Are the MCIDs for PROMIS, NDI, and ODI Instruments Among Patients With Spinal Conditions?
    Hung M; Saltzman CL; Kendall R; Bounsanga J; Voss MW; Lawrence B; Spiker R; Brodke D
    Clin Orthop Relat Res; 2018 Oct; 476(10):2027-2036. PubMed ID: 30179950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum Clinically Important Differences of the Hospital for Special Surgery Dysphagia and Dysphonia Inventory and Other Dysphagia Measurements in Patients Undergoing ACDF.
    Okano I; Ortiz Miller C; Salzmann SN; Hoshino Y; Shue J; Sama AA; Cammisa FP; Girardi FP; Hughes AP
    Clin Orthop Relat Res; 2020 Oct; 478(10):2309-2320. PubMed ID: 32282534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.